First Time Loading...

111 Inc
NASDAQ:YI

Watchlist Manager
111 Inc Logo
111 Inc
NASDAQ:YI
Watchlist
Price: 1.065 USD 3.4% Market Closed
Updated: Apr 30, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
111 Inc

Revenue
14.9B CNY
Cost of Revenue
-14.1B CNY
Gross Profit
849m CNY
Operating Expenses
-1.2B CNY
Operating Income
-350.1m CNY
Other Expenses
-42.6m CNY
Net Income
-392.7m CNY

Margins Comparison
111 Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
111 Inc
NASDAQ:YI
90m USD
6%
-2%
-3%
ZA
Clicks Group Ltd
JSE:CLS
72.4B Zac
22%
9%
6%
ZA
Dis-Chem Pharmacies Ltd
JSE:DCP
28.4B Zac
23%
5%
3%
US
Walgreens Boots Alliance Inc
NASDAQ:WBA
15.5B USD
19%
1%
-4%
BR
Raia Drogasil SA
BOVESPA:RADL3
44.1B BRL
30%
6%
3%
CN
Yifeng Pharmacy Chain Co Ltd
SSE:603939
43.3B CNY
38%
10%
6%
JP
MatsukiyoCocokara & Co
TSE:3088
922.7B JPY
35%
7%
5%
SA
Al Nahdi Medical Company SCJSC
SAU:4164
17.7B SAR
40%
11%
10%
MX
Corporativo Fragua SAB de CV
BMV:FRAGUAB
74.3B MXN
23%
7%
4%
JP
Cosmos Pharmaceutical Corp
TSE:3349
570.3B JPY
20%
3%
3%
CN
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
24.5B CNY
36%
8%
5%
Country CN
Market Cap 90m USD
Gross Margin
6%
Operating Margin
-2%
Net Margin
-3%
Country ZA
Market Cap 72.4B Zac
Gross Margin
22%
Operating Margin
9%
Net Margin
6%
Country ZA
Market Cap 28.4B Zac
Gross Margin
23%
Operating Margin
5%
Net Margin
3%
Country US
Market Cap 15.5B USD
Gross Margin
19%
Operating Margin
1%
Net Margin
-4%
Country BR
Market Cap 44.1B BRL
Gross Margin
30%
Operating Margin
6%
Net Margin
3%
Country CN
Market Cap 43.3B CNY
Gross Margin
38%
Operating Margin
10%
Net Margin
6%
Country JP
Market Cap 922.7B JPY
Gross Margin
35%
Operating Margin
7%
Net Margin
5%
Country SA
Market Cap 17.7B SAR
Gross Margin
40%
Operating Margin
11%
Net Margin
10%
Country MX
Market Cap 74.3B MXN
Gross Margin
23%
Operating Margin
7%
Net Margin
4%
Country JP
Market Cap 570.3B JPY
Gross Margin
20%
Operating Margin
3%
Net Margin
3%
Country CN
Market Cap 24.5B CNY
Gross Margin
36%
Operating Margin
8%
Net Margin
5%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
111 Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
111 Inc
NASDAQ:YI
90m USD
79%
-12%
-66%
-42%
ZA
Clicks Group Ltd
JSE:CLS
72.4B Zac
44%
14%
45%
36%
ZA
Dis-Chem Pharmacies Ltd
JSE:DCP
28.4B Zac
23%
6%
23%
14%
US
Walgreens Boots Alliance Inc
NASDAQ:WBA
15.5B USD
-35%
-7%
3%
2%
BR
Raia Drogasil SA
BOVESPA:RADL3
44.1B BRL
19%
6%
19%
14%
CN
Yifeng Pharmacy Chain Co Ltd
SSE:603939
43.3B CNY
17%
7%
19%
11%
JP
MatsukiyoCocokara & Co
TSE:3088
922.7B JPY
10%
7%
13%
9%
SA
Al Nahdi Medical Company SCJSC
SAU:4164
17.7B SAR
38%
17%
27%
27%
MX
Corporativo Fragua SAB de CV
BMV:FRAGUAB
74.3B MXN
22%
10%
35%
25%
JP
Cosmos Pharmaceutical Corp
TSE:3349
570.3B JPY
11%
6%
14%
10%
CN
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
24.5B CNY
20%
6%
17%
11%
Country CN
Market Cap 90m USD
ROE
79%
ROA
-12%
ROCE
-66%
ROIC
-42%
Country ZA
Market Cap 72.4B Zac
ROE
44%
ROA
14%
ROCE
45%
ROIC
36%
Country ZA
Market Cap 28.4B Zac
ROE
23%
ROA
6%
ROCE
23%
ROIC
14%
Country US
Market Cap 15.5B USD
ROE
-35%
ROA
-7%
ROCE
3%
ROIC
2%
Country BR
Market Cap 44.1B BRL
ROE
19%
ROA
6%
ROCE
19%
ROIC
14%
Country CN
Market Cap 43.3B CNY
ROE
17%
ROA
7%
ROCE
19%
ROIC
11%
Country JP
Market Cap 922.7B JPY
ROE
10%
ROA
7%
ROCE
13%
ROIC
9%
Country SA
Market Cap 17.7B SAR
ROE
38%
ROA
17%
ROCE
27%
ROIC
27%
Country MX
Market Cap 74.3B MXN
ROE
22%
ROA
10%
ROCE
35%
ROIC
25%
Country JP
Market Cap 570.3B JPY
ROE
11%
ROA
6%
ROCE
14%
ROIC
10%
Country CN
Market Cap 24.5B CNY
ROE
20%
ROA
6%
ROCE
17%
ROIC
11%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More